Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy.

By Helen Y Wang, Dean Anthony Lee, Guangyong Peng, Zhong Guo, Yanchun Li, Y. Kiniwa, E. Shevach, Rong‐Fu Wang. Immunity, 2004

599 citations recorded by the source corpus.

Regulatory T cells play an important role in the maintenance of immunological self-tolerance by suppressing immune responses against autoimmune diseases and cancer. Little is known, however, about the nature of the physiological target antigens for CD4(+) regulatory T (Treg) cells. Here we report the identification of the LAGE1 protein as a ligand for tumor-specific CD4(+) Treg cell clones generated from the tumor-infiltrating lymphocytes (TILs) of cancer patients. Phenotypic and functional analyses demonstrated that they were antigen-specific CD4(+) Treg cells expressing CD25 and GITR molecules and possessing suppressive activity on the proliferative response of naive CD4(+) T cells to anti-CD3 antibody stimulation. Ligand-specific activation and cell-cell contact were required for TIL102 Treg cells to exert suppressive activity on CD4(+) effector cells. These findings suggest that the presence of tumor-specific CD4(+) Treg cells at tumor sites may have a profound effect on the inhibition of T cell responses against cancer.

Subfields: Immunology

View Paper: https://www.semanticscholar.org/paper/597cfdfbff5efdef478aa3c223d2eb1e22561b70

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

  1. V. Bronte
  2. Paola Zanovello
  3. P. Serafini
  4. L. Dolcetti
  5. Ilaria Marigo
  6. M. Cho
  7. M. Viguier
  8. Louis Dubertret

Citations in the corpus